Sulfamylon

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved June 1998

Specific Treatments:

Burn Wounds

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Sulfamylon Powder for 5% solution has been approved for use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds. This is the first drug approved for this indication.